XML 43 R29.htm IDEA: XBRL DOCUMENT v3.21.1

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	23.  SUBSEQUENT EVENTS The Department of Health and Human Services entered into a contract with the Company on February 12, 2021 to supply low dead space safety syringes.  The base price for the contract and purchase order is $54,217,800 for the five-month base period of performance from February 15, 2021 to July 14, 2021.  Such price includes both the fixed price for the products as well as cost reimbursement for freight.  The terms of the contract allow for extensions at the option of the U.S. government for up to seven additional one-month periods.  If all option periods are exercised, the value of the contract could increase by an additional $92,772,680, including the price of the products and freight reimbursement.  On March 16, 2021, the Company approved the 2021 Stock Option Plan (the “Plan”) and set aside and reserved 2,000,000 shares of Common Stock for issuance pursuant to the Plan.  The Plan is subject to shareholder approval at the May 11, 2021 shareholder meeting.  The Plan provides for the granting of incentive stock options and non-qualified stock options at a price equal to at least 100% of the fair market value of the Company’s Common Stock as of the date of grant.  Participants in the Plan may include employees, consultants, and non-employee Directors.  On March 16, 2021, the Company approved option grants to purchase 1,000,000,  250,000, and 100,000 shares of Common Stock to the Company’s chief executive officer, general counsel, and chief financial officer, respectively.  These shares will vest in their entirety three years from the grant date.  No award shall be exercisable unless and until the Plan has been approved by the shareholders.

X

- References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

+ Details

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration